Advanced search
Publication Cover
Therapeutic Delivery Volume 3, 2012 - Issue 6
Submit an article Journal homepage
100
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Distribution of Effervescent Inhalable Nanoparticles After Pulmonary Delivery: an In Vivo Study

MHD Kamal Al-Hallak1 Faculty of Pharmacy & Pharmaceutical Sciences University of AlbertaEdmontonABT6G 2N8Canada;2 Faculty of Pharmacy Damascus UniversityDamascusSyrian Arab Republic
,
Muhammad K Sarfraz1 Faculty of Pharmacy & Pharmaceutical Sciences University of AlbertaEdmontonABT6G 2N8Canada;3 Faculty of Pharmacy & Alternative Medicine The Islamia University of BahawalpurBahawalpurPakistan
,
Shirzad Azarmi1 Faculty of Pharmacy & Pharmaceutical Sciences University of AlbertaEdmontonABT6G 2N8Canada;4 Research Center for Pharmaceutical Nanotechnology Faculty of Pharmacy Tabriz University of Medical SciencesTabrizIran
,
Wilson H Roa5 Department of Oncology Cross Cancer Institute University of Alberta 11560 University AvenueEdmontonABT6G 1Z2Canada
,
Warren H Finlay6 Department of Mechanical Engineering University of AlbertaEdmontonABT6G 2G8Canada
,
Claude Rouleau7 Fisheries & Oceans Canada Maurice-Lamontagne InstituteMont-JoliQCG5H 3Z4Canada
&
Raimar Löbenberg1 Faculty of Pharmacy & Pharmaceutical Sciences University of AlbertaEdmontonABT6G 2N8Canada;8 Faculty of Pharmacy & Pharmaceutical Sciences University of AlbertaEdmontonABT6G [email protected]
 show all
Pages 725-734 | Published online: 01 Jun 2012

References

  • O‘Connor SJ . Review of the incidence, prevalence, mortality and causative factors for lung cancer in Europe. Eur. J. Cancer47(Suppl. 3), S346–S347 (2011).
  • Soerjomataram I , BarendregtJJ, GartnerC, KunstA, MollerH, AvendanoM. Reducing inequalities in lung cancer incidence through smoking policies. Lung Cancer73(3), 268–273 (2011).
  • Dela Cruz CS , TanoueLT, MatthayRA. Lung cancer: epidemiology, etiology, and prevention. Clin. Chest Med.32(4), 605–644 (2011).
  • Mcerlean A , GinsbergMS. Epidemiology of lung cancer. Semin. Roentgenol.46(3), 173–177 (2011).
  • Hazarika M , WhiteRM, JohnsonJR, PazdurR. FDA drug approval summaries: pemetrexed (Alimta). Oncologist9(5), 482–488 (2004).
  • Cohen MH , WilliamsGA, SridharaR, ChenG, PazdurR. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist8(4), 303–306 (2003).
  • Cohen MH , JohnsonJR, ChenYF, SridharaR, PazdurR. FDA drug approval summary: erlotinib (Tarceva) tablets. Oncologist10(7), 461–466 (2005).
  • Eaton KD , MartinsRG. Maintenance chemotherapy in non-small cell lung cancer. J. Natl Compr. Canc. Netw.8(7), 815–821 (2010).
  • Kim YH , MishimaM. Maintenance chemotherapy for non-small-cell lung cancer. Cancer Treat. Rev.37(7), 505–510 (2011).
  • Roa WH , AzarmiS, Al-HallakMH, FinlayWH, MaglioccoAM, LobenbergR. Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model. J. Control. Release150(1), 49–55 (2011).
  • Verdun C , BrasseurF, VranckxH, CouvreurP, RolandM. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles. Cancer Chemother. Pharmacol.26(1), 13–18 (1990).
  • Payan JP , BinetS, BeydonD, FerrariE. Bio-distribution study of 1,2-diethylbenzene and its main metabolites by whole-body autoradiography and tissue homogenates. Arch. Toxicol.82(9), 591–600 (2008).
  • Paddock SW . Confocal laser scanning microscopy. Biotechniques27(5), 992–996, 998–1002, 1004 (1999).
  • Azarmi S , TaoX, ChenHet al. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int. J. Pharm. 319(1–2), 155–161 (2006).
  • Al-Hallak MH , SarfrazMK, AzarmiS, KohanMH, RoaWH, LobenbergR. Microcalorimetric method to assess phagocytosis: macrophage–nanoparticle interactions. AAPS J.13(1), 20–29 (2011).
  • Azarmi S , LobenbergR, RoaWH, TaiS, FinlayWH. Formulation and in vivo evaluation of effervescent inhalable carrier particles for pulmonary delivery of nanoparticles. Drug Dev. Ind. Pharm.34(9), 943–947 (2008).
  • Cheow WS , NgML, KhoK, HadinotoK. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants. Int. J. Pharm.404(1–2), 289–300 (2011).
  • Al-Hallak MH , AzarmiS, SunCet al. Pulmonary toxicity of polysorbate-80-coated inhalable nanoparticles; in vitro and in vivo evaluation. AAPS J. 12(3), 294–299 (2010).
  • Rouleau C , KohliJ. Distribution of 14C-labelled atrazine, methoxychlor, glyphosate and bisphenol-A in goldfish studied by whole-body autoradiography (WBARG). Water Qual. Res. J. Can.43(4), 265–274 (2008).
  • Rouleau C , XiongZH, PacepaviciusG, HuangGL. Uptake of waterborne tributyltin in the brain of fish: axonal transport as a proposed mechanism. Environ. Sci. Technol.37(15), 3298–3302 (2003).
  • Calvo PL Vila-Jato JL, Alonso MJ.Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J. Pharm. Sci.85(5), 530–536 (1996).
  • Cosco D , CeliaC, CilurzoF, TrapassoE, PaolinoD. Colloidal carriers for the enhanced delivery through the skin. Expert Opin. Drug Deliv.5(7), 737–755 (2008).
  • Azarmi S , RoaWH, LobenbergR. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv. Drug Deliv. Rev.60(8), 863–875 (2008).
  • Al-Hallak MK , SarfrazMK, AzarmiS, RoaWH, FinlayWH, LöbenbergR. Pulmonary delivery of inhalable nanoparticles: dry powder inhalers. Therapeutic Delivery2(10), 1313–1324 (2011).
  • Kaialy W , AlhalawehA, VelagaSP, NokhodchiA. Effect of carrier particle shape on dry powder inhaler performance. Int. J. Pharm.421(1), 12–23 (2011).
  • Sung JC , PulliamBL, EdwardsDA. Nanoparticles for drug delivery to the lungs. Trends Biotechnol.25(12), 563–570 (2007).
  • Suk JS , LaiSK, BoylanNJ, DawsonMR, BoyleMP, HanesJ. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomedicine (Lond.)6(2), 365–375 (2011).
  • Gelperina S , KisichK, IsemanMD, HeifetsL. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am. J. Respir. Crit. Care Med.172(12), 1487–1490 (2005).
  • Elder A , GeleinR, SilvaVet al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 114(8), 1172–1178 (2006).
  • Al-Hallak KM , AzarmiS, Anwar-MohamedA, RoaWH, LobenbergR. Secondary cytotoxicity mediated by alveolar macrophages: a contribution to the total efficacy of nanoparticles in lung cancer therapy? Eur. J. Pharm. Biopharm.76(1), 112–119 (2010).
  • Sung JC , PadillaDJ, Garcia-ContrerasLet al. Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm. Res. 26(8), 1847–1855 (2009).
  • Tomoda K , OhkoshiT, HirotaKet al. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Colloids Surf. B Biointerfaces 71(2), 177–182 (2009).
  • Furuyama A , KannoS, KobayashiT, HiranoS. Extrapulmonary translocation of intratracheally instilled fine and ultrafine particles via direct and alveolar macrophage-associated routes. Arch. Toxicol.83(5), 429–437 (2009).
  • Videira MA , BotelhoMF, SantosAC, GouveiaLF, De Lima JJ, Almeida AJ. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. Drug Target.10(8), 607–613 (2002).
  • O‘Byrne K . The link between inflammation and cancer: wounds that do not heal. Angus GD, Burkhard H (Eds). Springer, New York, NY, USA (2006).
  • Montuenga LM , PioR. Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10. Eur. Respir. J.30(4), 608–610 (2007).
  • Condeelis J , PollardJW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell124(2), 263–266 (2006).
  • Haley B , FrenkelE. Nanoparticles for drug delivery in cancer treatment. Urol. Oncol.26(1), 57–64 (2008).
  • Kante B , CouvreurP, LenaertsV. Tissue distribution of [3H] actinomycin D adsorbed on polybutylcyanoacrylate nanoparticles. Int. J. Pharm.7(1), 45–53 (1980).
  • Johansen PB . Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude mouse. Cancer Chemother. Pharmacol.5(4), 267–270 (1981).
  • Wartenberg M , AckerH. Induction of cell death by Doxorubicin in multicellular spheroids as studied by confocal laser scanning microscopy. Anticancer Res.16(2), 573–579 (1996).
  • Lenaerts V , CouvreurP, Christiaens-LeyhDet al. Degradation of poly (isobutyl cyanoacrylate) nanoparticles. Biomaterials 5(2), 65–68 (1984).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.